These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. JAMA; 2015 Jan 13; 313(2):165-73. PubMed ID: 25585328 [Abstract] [Full Text] [Related]
4. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. Black DM, Jiang J, Kuerer HM, Buchholz TA, Smith BD. JAMA Surg; 2014 Aug 13; 149(8):788-96. PubMed ID: 25073831 [Abstract] [Full Text] [Related]
5. Socioecologic Factors and Racial Differences in Breast Cancer Multigene Prognostic Scores in US Women. Parab AZ, Kong A, Lee TA, Kim K, Nutescu EA, Malecki KC, Hoskins KF, Calip GS. JAMA Netw Open; 2024 Apr 01; 7(4):e244862. PubMed ID: 38568689 [Abstract] [Full Text] [Related]
7. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. Menashe I, Anderson WF, Jatoi I, Rosenberg PS. J Natl Cancer Inst; 2009 Jul 15; 101(14):993-1000. PubMed ID: 19584327 [Abstract] [Full Text] [Related]
8. Social Determinants of Racial Disparities in Breast Cancer Mortality Among Black and White Women. Babatunde OA, Eberth JM, Felder T, Moran R, Truman S, Hebert JR, Zhang J, Adams SA. J Racial Ethn Health Disparities; 2021 Feb 15; 8(1):147-156. PubMed ID: 32385849 [Abstract] [Full Text] [Related]
9. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data. Schinkel JK, Zahm SH, Jatoi I, McGlynn KA, Gallagher C, Schairer C, Shriver CD, Zhu K. Cancer Causes Control; 2014 Aug 15; 25(8):959-68. PubMed ID: 24839049 [Abstract] [Full Text] [Related]
10. Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial. Sadigh G, Gray RJ, Sparano JA, Yanez B, Garcia SF, Timsina LR, Obeng-Gyasi S, Gareen I, Sledge GW, Whelan TJ, Cella D, Wagner LI, Carlos RC. JAMA Oncol; 2022 Apr 01; 8(4):579-586. PubMed ID: 35175284 [Abstract] [Full Text] [Related]
11. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women. Hoskins KF, Danciu OC, Ko NY, Calip GS. JAMA Oncol; 2021 Mar 01; 7(3):370-378. PubMed ID: 33475714 [Abstract] [Full Text] [Related]
12. Characteristics associated with differences in survival among black and white women with breast cancer. Silber JH, Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, Wang M, Niknam BA, Ludwig JM, Wang W, Even-Shoshan O, Fox KR. JAMA; 2013 Jul 24; 310(4):389-97. PubMed ID: 23917289 [Abstract] [Full Text] [Related]
14. Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women. Barber LE, Zirpoli GR, Cozier YC, Rosenberg L, Petrick JL, Bertrand KA, Palmer JR. Breast Cancer Res; 2021 Nov 22; 23(1):108. PubMed ID: 34809694 [Abstract] [Full Text] [Related]
18. Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities. Rauscher GH, Silva A, Pauls H, Frasor J, Bonini MG, Hoskins K. Breast Cancer Res Treat; 2017 Jun 22; 163(2):321-330. PubMed ID: 28251385 [Abstract] [Full Text] [Related]
19. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources. Akinyemiju T, Moore JX, Ojesina AI, Waterbor JW, Altekruse SF. Breast Cancer Res Treat; 2016 Jun 22; 157(3):575-86. PubMed ID: 27255533 [Abstract] [Full Text] [Related]